Graham Frcp Jackson

Graham Frcp Jackson's AcademicInfluence.com Rankings

Graham Frcp Jackson

Medical

#2820

World Rank

#3259

Historical Rank

Urology

#22

World Rank

#23

Historical Rank

medical Degrees

Graham Frcp Jackson

Philosophy

#8069

World Rank

#11379

Historical Rank

Logic

#5096

World Rank

#6458

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Graham Frcp Jackson's Degrees

Masters Medicine University of Oxford

Why Is Graham Frcp Jackson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Graham Frcp Jackson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Summary of the recommendations on sexual dysfunctions in men. (2004) (825)
Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial. (2002) (706)
Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator (2003) (420)
The Princeton III Consensus recommendations for the management of erectile dysfunction and cardiovascular disease. (2012) (382)
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). (2005) (379)
Management of sexual dysfunction in patients with cardiovascular disease: recommendations of the Princeton Consensus Panel. (2000) (378)
International, randomized, controlled trial of lamifiban (a platelet glycoprotein IIb/IIIa inhibitor), heparin, or both in unstable angina (1998) (351)
A systematic review of the association between erectile dysfunction and cardiovascular disease. (2014) (350)
The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine. (2006) (333)
Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. (2005) (317)
Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 Diabetes (2011) (304)
Why patients do not attend cardiac rehabilitation: role of intentions and illness beliefs (1999) (292)
Factors associated with cardiac rehabilitation attendance: a systematic review of the literature (2002) (277)
Erectile dysfunction and coronary artery disease prediction: evidence‐based guidance and consensus (2010) (210)
Relation of erectile dysfunction to angiographic coronary artery disease. (2003) (209)
Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men. (2004) (158)
Time course of the interaction between tadalafil and nitrates. (2003) (158)
IS ERECTILE DYSFUNCTION A MARKER FOR CARDIOVASCULAR DISEASE? (2001) (154)
Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database (2009) (148)
Endothelial dysfunction links erectile dysfunction to heart disease (2005) (146)
Erectile dysfunction in the cardiovascular patient. (2013) (136)
Extra-articular features of benign joint hypermobility syndrome. (1996) (133)
Endothelial function and dysfunction (2004) (121)
ABC of heart failure. Pathophysiology. (2000) (119)
Cardiovascular risk, drugs and erectile function – a systematic analysis (2011) (118)
Cardiovascular aspects of sexual medicine. (2010) (114)
A qualitative study investigating patients' beliefs about cardiac rehabilitation (2005) (114)
Mind the (gender) gap (2011) (107)
Fluvastatin for Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention (2002) (106)
Assessing patients’ beliefs about cardiac rehabilitation as a basis for predicting attendance after acute myocardial infarction (2006) (97)
Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks (2010) (97)
ERECTILE DYSFUNCTION: IS THERE SILENT OBSTRUCTIVE CORONARY ARTERY DISEASE? (2001) (96)
Efficacy of nifedipine and isosorbide mononitrate in combination with atenolol in stable angina (1991) (95)
Coronary and systemic hemodynamic effects of sildenafil citrate: from basic science to clinical studies in patients with cardiovascular disease. (2002) (89)
A SYSTEMATIC APPROACH TO ERECTILE DYSFUNCTION IN THE CARDIOVASCULAR PATIENT: A CONSENSUS STATEMENT – UPDATE 2002 (2002) (89)
A SYSTEMATIC APPROACH TO ERECTILE DYSFUNCTION IN THE CARDIOVASCULAR PATIENT: A CONSENSUS STATEMENT (1999) (87)
Erectile dysfunction and statin treatment in high cardiovascular risk patients (2006) (83)
Past, present, and future: a 7‐year update of Viagra® (sildenafil citrate) (2005) (83)
Prognostic utility of erectile dysfunction for cardiovascular disease in younger men and those with diabetes. (2012) (77)
Continuity equation and Gorlin formula compared with directly observed orifice area in native and prosthetic aortic valves. (1992) (77)
All men with vasculogenic erectile dysfunction require a cardiovascular workup. (2014) (74)
Cardiovascular safety update of Tadalafil: retrospective analysis of data from placebo-controlled and open-label clinical trials of Tadalafil with as needed, three times-per-week or once-a-day dosing. (2006) (73)
Cardiovascular safety of sildenafil citrate (Viagra): an updated perspective. (2006) (71)
Erectile dysfunction and silent coronary artery disease: abnormal computed tomography coronary angiogram in the presence of normal exercise ECGs (2008) (69)
QT Prolongation on the Electrocardiogram in Diabetic Autonomic Neuropathy (1990) (66)
Erectile dysfunction: a marker of silent coronary artery disease. (2006) (65)
Prevention of cardiovascular disease by the early identification of erectile dysfunction (2008) (63)
Assessing the problem of counterfeit medications in the United Kingdom (2012) (63)
Erectile dysfunction and lower urinary tract symptoms: a consensus on the importance of co-diagnosis (2013) (63)
ERECTILE DYSFUNCTION: CARDIOVASCULAR RISK AND THE ROLE OF THE CARDIOLOGIST (2003) (62)
Sexual dysfunction and diabetes (2004) (61)
Improvement of myocardial metabolism in coronary arterial disease by beta-blockade. (1977) (59)
Efficacy of monotherapy compared with combined antianginal drugs in the treatment of chronic stable angina pectoris: a meta-analysis (2002) (58)
The assessment of vascular risk in men with erectile dysfunction: the role of the cardiologist and general physician (2013) (49)
Diagnosis and treatment of erectile dysfunction for reduction of cardiovascular risk. (2013) (49)
Reassessment of failed beta-blocker treatment in angina pectoris by peak-exercise heart rate measurements. (1975) (49)
Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME) (2016) (48)
Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol. (1978) (48)
Ventricular stroke work loss: validation of a method of quantifying the severity of aortic stenosis and derivation of an orifice formula. (1990) (48)
Update on clinical trials of tadalafil demonstrates no increased risk of cardiovascular adverse events. (2004) (46)
The Bolger conference on PDE-5 inhibition and HIV risk: implications for health policy and prevention. (2006) (43)
Vascular risk factors and erectile dysfunction (2008) (43)
Acute and chronic management strategies (2000) (42)
The metabolic syndrome and erectile dysfunction: multiple vascular risk factors and hypogonadism. (2006) (40)
Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity. (2009) (39)
Colour flow Doppler mapping in the assessment of prosthetic valve regurgitation. (1989) (39)
Factors associated with preference for sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy: post hoc analysis of data from a multicentre, randomized, open‐label, crossover study (2007) (39)
Non-atherosclerotic coronary artery aneurysms: two case reports (1997) (39)
Non-drug management (2000) (39)
Coronary artery disease and women (1994) (37)
Asymmetric dimethyl arginine levels correlate with cardiovascular risk factors in patients with erectile dysfunction. (2006) (36)
Genetic segregation analysis of familial mitral valve prolapse shows no linkage to fibrillar collagen genes. (1989) (36)
Murmurs in pregnancy: an audit of echocardiography. (1992) (35)
COMBINATION THERAPY IN ANGINA: A REVIEW OF COMBINED HAEMODYNAMIC TREATMENT AND THE ROLE FOR COMBINED HAEMODYNAMIC AND CARDIAC METABOLIC AGENTS (2001) (33)
Development of UK recommendations on treatment for post-surgical erectile dysfunction (2013) (32)
Aspirin modifies nitric oxide synthase activity in platelets: effects of acute versus chronic aspirin treatment. (2003) (32)
Diagnosis of coronary artery disease by estimation of coronary sinus lactate. (1978) (31)
Early exercise testing and coronary angiography after uncomplicated myocardial infarction. (1982) (30)
Angina with normal coronary arteriograms. Value of coronary sinus lactate estimation in diagnosis and treatment. (1978) (30)
SILDENAFIL FOR PRIMARY PULMONARY HYPERTENSION: SHORT AND LONG‐TERM SYMPTOMATIC BENEFIT (2002) (30)
Erectile dysfunction as a risk factor for coronary heart disease: implications for prevention (2007) (29)
ORIGINAL RESEARCH—PHOSPHODIESTERASE INHIBITOR THERAPY FOR ED: Pharmacotherapy for Erectile Dysfunction (2004) (29)
Erectile dysfunction in general medicine. (2013) (28)
Cardiovascular risk factors determine erectile and arterial function response to sildenafil. (2006) (28)
Hemodynamic and exercise effects of phosphodiesterase 5 inhibitors. (2005) (27)
Erectile dysfunction and asymptomatic coronary artery disease: frequently detected by computed tomography coronary angiography but not by exercise electrocardiography (2013) (27)
Erectile dysfunction and cardiac disease: Recommendations of the second princeton conference (2006) (27)
Phosphodiesterase type 5 inhibitors improve endothelial function and may benefit cardiovascular conditions. (2013) (27)
Sexual Response in Cardiovascular Disease (2009) (27)
Erectile dysfunction as a predictor of coronary artery disease (2011) (27)
VIAGRA ON THE INTERNET: UNSAFE SEXUAL PRACTICE (2002) (27)
Sexual intercourse and angina pectoris. (1978) (27)
The Gorlin formula validated against directly observed orifice area in porcine mitral bioprostheses. (1989) (26)
Increased diastolic blood pressure response to exercise testing when coronary artery disease is suspected. An indication of severity. (1985) (25)
The importance of risk factor reduction in erectile dysfunction (2007) (25)
Stable angina: drugs, angioplasty or surgery? (1997) (24)
PHOSPHODIESTERASE 5 INHIBITION: EFFECTS ON THE CORONARY VASCULATURE (2001) (24)
ORIGINAL RESEARCH—PHARMACOTHERAPY: Successful Withdrawal of Oral Long‐Acting Nitrates to Facilitate Phosphodiesterase Type 5 Inhibitor Use in Stable Coronary Disease Patients with Erectile Dysfunction (2005) (23)
Erectile dysfunction and cardiovascular disease (2013) (23)
Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris. (1975) (22)
Gender differences in cardiovascular disease prevention (2008) (22)
Early exercise testing and elective coronary artery bypass surgery after uncomplicated myocardial infarction. Effect on morbidity and mortality. (1984) (22)
The continuity equation tested in a bileaflet aortic prosthesis. (1991) (21)
The importance of risk factor reduction in erectile dysfunction (2007) (21)
Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemia. (1994) (21)
Management of sexual dysfunction in patients with cardiovascular disease: recommendations of The Princeton Consensus Panel. (2000) (20)
Erectile dysfunction and coronary disease: evaluating the link. (2012) (20)
Pathophysiology (1951) (20)
Erectile dysfunction and cardiovascular disease (1999) (20)
Stable angina: maximal medical therapy is not the same as optimal medical therapy (2000) (19)
Faking it: the dangers of counterfeit medicine on the internet (2009) (19)
Denial (1980) (19)
SMOKING CESSATION: A CONSENSUS STATEMENT WITH SPECIAL REFERENCE TO PRIMARY CARE (2001) (18)
Comparative anti-arrhythmic efficacy of mexiletine, procainamide and tolamolol in patients with symptomatic ventricular arrhythmias. (1977) (18)
A randomised double-blind crossover study of isosorbide mononitrate and nifedipine retard in chronic stable angina. (1989) (18)
Reciprocal change in ST segment in acute myocardial infarction: correlation with findings on exercise electrocardiography and coronary angiography. (1985) (18)
Limitations of Doppler ultrasound in the assessment of the function of prosthetic mitral valves. (1990) (17)
ORIGINAL RESEARCH—PHARMACOTHERAPY: Hemodynamic Effects of Sildenafil Citrate and Isosorbide Mononitrate in Men with Coronary Artery Disease and Erectile Dysfunction (2005) (16)
Erectile dysfunction: the need to be evaluated, the right to be treated. (2005) (16)
Role of exercise treadmill testing in the management of erectile dysfunction: a joint cardiovascular/erectile dysfunction clinic (2003) (15)
Tibolone and the cardiovascular system (2001) (15)
At times like these.. (2002) (15)
THE ROLE OF STATINS IN ACUTE CORONARY SYNDROMES: MANAGING THE UNMET NEED (2000) (15)
Sexual intercourse and angina pectoris. (1978) (14)
Doppler echocardiography appearance of cusp tears in tissue valve prostheses (1987) (14)
Successful withdrawal of oral long-acting nitrates to facilitate phosphodiesterase type 5 inhibitor use in stable coronary disease patients with erectile dysfunction. (2005) (14)
Raised exercise diastolic blood pressure as indicator of ischaemic left ventricular dysfunction (1991) (13)
Phosphodiesterase type 5 inhibition in cardiovascular disease: experimental models and potential clinical applications (2002) (13)
Effect of changes in heart rate on pressure half time in normally functioning mitral valve prostheses. (1988) (13)
Evidence based medicine inevitably increases testosterone prescribing (2012) (13)
Ambulatory monitoring in the controlled assessment of anti-arrhythmic drug therapy. (1976) (13)
Isosorbide-5-mononitrate--effective monotherapy in chronic stable angina. (1985) (12)
ABC of heart failure: Non-drug management (2000) (12)
Is MRI a safe procedure in patients with coronary stents in situ? (1997) (12)
Oral labetalol in the management of stable angina pectoris in normotensive patients. (1985) (12)
Testosterone deficiency syndrome (TDS) and the heart. (2010) (11)
Erectile dysfunction, like diabetes, should be considered a ‘cardiovascular equivalent’ (2005) (11)
Erectile dysfunction and vascular risk: Let's get it right. (2006) (11)
Whole body nitric oxide production is not decreased in patients with coronary atherosclerosis but is inversely related to plasma homocysteine. (2008) (11)
Gender‐based cardiometabolic risk evaluation in minority and non‐minority men grading the evidence of non‐traditional determinants of cardiovascular risk (2011) (10)
Erectile dysfunction: a window of opportunity for preventing vascular disease? (2003) (10)
The inotropic effects of UK 14,275, a phosphodiesterase inhibitor, in man. (1978) (10)
JUPITER: wake up and smell the coffee – The absolute and relative merits of statin use (2009) (10)
The role of captopril as single therapy in hypertension and angina pectoris. (1991) (10)
Spontaneous recanalization of the internal carotid artery resulting in thromboembolic occlusion of the ipsilateral ophthalmic artery and visual loss (2009) (10)
THE LONG‐TERM SAFETY AND TOLERABILITY OF TRANSDERMAL GLYCERYL TRINITRATE, WHEN USED WITH A PATCH‐FREE INTERVAL IN PATIENTS WITH STABLE ANGINA (1993) (9)
A Metabolic Approach to the Management of Ischemic Heart Disease (2003) (9)
“Oh … by the way … ”: doorknob syndrome (2005) (9)
Sexual Medicine Society of North America (2006) (8)
PDE5 inhibitors: looking beyond ED (2003) (8)
Pacemaker‐Induced Superior Vena Cava Obstruction: Bypass Using the Intact Azygous Vein (1999) (8)
Transvenous cardioversion for the management of recurrent ventricular arrhythmias. (1987) (8)
A DOUBLE‐BUND CROSSOVER TRIAL OF ATENOLOL, ENALAPRIL AND THE FIXED COMBINATION OF ATENOLOL AND NIFEDIPINE IN MILD AND MODERATE HYPERTENSION (1993) (8)
CONVULSIVE SYNCOPE IN YOUNG ADULTS: THINK OF A CARDIAC CAUSE (2001) (8)
The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines, new challenges (2006) (8)
Aspirin and clopidogrel treatment impair nitric oxide biosynthesis by platelets. (2008) (7)
Improvement ofmyocardial metabolism incoronary arterial disease bybeta-blockade (1977) (7)
Treatment of Erectile Dysfunction in Patients with Cardiovascular Disease (2012) (7)
Viagra is well-tolerated by subjects with stable angina and erectile dysfunction during incremental treadmill exercise (2002) (7)
Problem solved: erectile dysfunction (ED) = early death (ED) (2010) (7)
Torcetrapib: when global risk reduction goes ‘off target’ (2008) (7)
Cardiovascular safety in erectile dysfunction treatment (2002) (7)
Smoking: suicide for some, manslaughter for others – time for a ban in all public places (2004) (7)
Calcium antagonists: when the content does not justify the headline (1995) (6)
Hemodynamic effects of sildenafil citrate and isosorbide mononitrate in men with coronary artery disease and erectile dysfunction. (2005) (6)
PDE 5 inhibitors and HIV risk: current concepts and controversies (2005) (6)
The empty chair (2006) (6)
CURE – clopidogrel's major advance (2001) (6)
Haemodynamic and metabolic agents in the treatment of stable angina: publication review. (2001) (6)
Chelation therapy is TACT‐less (2008) (6)
How should a patient presenting with unstable angina and a recent stroke be managed? (1995) (6)
Never Mind the Content, Measure the Impact: Spin Bowling for Journal Impact Factors vs. the Importance of Patient Impact (2010) (6)
The Hatle orifice area formula tested in normal bileaflet mechanical mitral prostheses. (1992) (6)
The effect of flow on Doppler estimates of bioprosthetic mitral valve function in vitro. (1989) (6)
Sex, The Heart and Erectile Dysfunction (2004) (6)
Ambulatory electrocardiography: an open‐access service for general practitioners (1989) (6)
Sex, the Heart and Erectile Dysfunction: Pocketbook (2004) (5)
Come fly with me: jet lag and melatonin (2009) (5)
Standards not targets (2009) (5)
Waiting for coronary bypass surgery: a lottery that fails to prevent avoidable death (1998) (5)
Statins and coronary artery disease--it's the clinical endpoints that count. (1997) (5)
1195: Interaction Between the Phosphodiesterase 5 Inhibitor, Tadalafil, and Two Alpha-Blockers: Doxazosin and Tamsulosin (2004) (5)
Erectile dysfunction and hypertension. (2002) (5)
Tobacco: the most important preventable cause of cardiovascular disease (2010) (5)
Metabolic approach to heart failure – evidence that trimetazidine improves symptoms, left ventricular function and possibly prognosis (2006) (5)
Should erectile dysfunction be treated as secondary prevention for coronary disease? (2006) (5)
Vascular risk factors and erectile dysfunction: ‘sexing‐up’ the importance of lifestyle changes (2007) (5)
Letter: tolamolol in treatment of angina pectoris. (1975) (5)
Placebo controlled double-blind randomised cross-over trial of atenolol, hydrochlorothiazide and amiloride, and the combination (Kalten) in patients over 60 years of age. (1986) (5)
ERECTILE DYSFUNCTION MIGHT PREDICT SILENT UNOBSTRUCTIVE CORONARY ARTERY DISEASE (2008) (4)
Erectile dysfunction in congenital heart disease (2009) (4)
Prediction of Coronary Artery Disease by Erectile Function Status: Evidence-Based Data. (2013) (4)
Sildenafil (Viagra) ‘reaches the parts other drugs cannot reach‘ (1998) (4)
Cardiovascular Issues in Male and Female Sexual Dysfunction (2008) (4)
A male cardiovascular sexual health clinic (2002) (4)
Erectile Dysfunction: A management algorithm (2004) (4)
Remembering Paul. (2002) (4)
UNSTABLE ANGINA: A REVIEW AND PRACTICAL GUIDE TO MANAGEMENT (1999) (4)
Efficacy of intermittent (eight hours off) transdermal nitrate therapy in stable angina. (1994) (4)
The pathophysiology of angina pectoris with normal coronary arteriograms. Histopathological and metabolic correlations with coronary vasospasm. (1983) (4)
Lipid‐lowering therapy: guidelines, targets and the need for action (1998) (4)
Quality and quantity of life (2009) (4)
GUSTO: Is science or money talking? (1993) (4)
The use of sildenafil in heart disease. (2000) (4)
Male lower urinary tract symptoms and sildenafil (2007) (4)
Sildenafil (Viagra™): new data, new confidence in treating erectile dysfunction in the cardiovascular patient (2002) (4)
Postmenopausal HRT ‐ a role for tamoxifen? (1997) (4)
Testosterone reducing cardiovascular risk – looks promising but randomised trials needed (2008) (3)
An Interim Report on the Efficacy of Isosorbide-5-Mononitrate in a Sustained Release Formulation in Patients with Stable Angina (1987) (3)
Lower urinary tract symptoms (LUTS) – an independent risk factor for cardiovascular disease (CVD) (2015) (3)
Men’s health left hung out to dry: why men die earlier and suffer more (2009) (3)
The cost of healthcare: assessing the evidence (2011) (3)
Blood pressure lowering – is degree more important than method? (2005) (3)
Testosterone – not just a replacement therapy (2006) (3)
Reclaiming the National Health Service from political control (2007) (3)
Stitched up by fake drugs: counterfeits need counteraction (2010) (3)
Haemodynamic changes during dobutamine stress echocardiography in patients with and without ischaemia. (1997) (3)
Erectile dysfunction and the heart–what's new? (2006) (3)
Ama Sumani: avoidable death of a deportee (2008) (3)
Aspirin: not currently for primary prevention in diabetes (2009) (3)
GLYCOPROTEIN IIB/IIIA ANTAGONISTS: DO THEY HAVE A ROLE IN THE MANAGEMENT OF UNSTABLE ANGINA? (1999) (3)
Stop: The medical and human rights scandal in Bahrain (2011) (3)
CORONA – rosuvastatin in older patients with systolic heart failure (2007) (3)
Between the bombs (2003) (3)
WHEN IS AN AORTIC VALVE PROSTHESIS TOO SMALL? THE NEED FOR DOBUTAMINE STRESS ECHOCARDIOGRAPHY (2000) (3)
The Value of VALUE: the importance of lowering blood pressure quickly (2004) (3)
MAKING PROGRESS IN STABLE PATIENTS POST STROKE OR TRANSIENT ISCHAEMIC ATTACK: IMPLICATIONS FOR GENERAL PRACTICE (2003) (3)
ACUTE AND CHRONIC EFFECTS OF ONCE‐DAILY ISOSORBIDE‐5‐MONONITRATE ON THE EXERCISE CAPACITY OF PATIENTS WITH ANGINA PECTORIS TREATED WITH A BETA‐BLOCKING DRUG (1991) (3)
Calcium antagonists: a scandal in need of an inquiry (2003) (3)
Calcium antagonists: never let the truth get in the way of a good story (1996) (3)
ATLAS: high dose lisinopril is superior to low dose in heart failure (1998) (3)
Mens Health 2007: the need for action (2007) (2)
NO problem: arterial and venous endothelial function and erectile dysfunction. (2011) (2)
Generic prescribing – cost saving chaos (2005) (2)
ACE Inhibitors: Current Use and Future ProspectsMichaelSchachter, Ed. London: Martin Dunitz, 1995, 278 pp, £49.95 (1995) (2)
Echocardiographic appearance of pulmonary artery stenosis. (1990) (2)
Ranolazine – a nicely timed new medical therapy for stable angina (2007) (2)
ANGINA AND NORMAL CORONARY ARTERIES (1976) (2)
ENDURANCE: getting the timing right (2009) (2)
Statins – threatening the evidence base of effectiveness and safety (2004) (2)
239 Testosterone treatment is not associated with increased risk of prostate cancer or cardiovascular events: Results from the Registry of Hypogonadism in Men (RHYME) (2015) (2)
Premenopausal risk factors for coronary artery disease (2002) (2)
Calcium supplements and cardiovascular disease – A response (2011) (2)
Erratum: Pharmacotherapy for erectile dysfunction (Journal of Sexual Medicine (2004) vol. 1 (128) 10.1111/j.1743-6109.2004.04021.x) (2005) (2)
Diabetic and hypertension guidelines updated (2004) (2)
Treatment of Erectile Dysfunction in Men with Heart Disease (2007) (2)
Practical management of ischaemic heart disease (1988) (2)
Finding time for family life and personal health (2005) (2)
Erectile dysfunction: a marker of increased cardiovascular risk. (2014) (2)
Expert abuse syndrome: the scapegoating of Roy Meadow (2005) (2)
Managing stable angina: time to re‐evaluate medical therapy (1997) (2)
The neglected elderly (2010) (2)
Evidence‐based freedom: first do no harm (2012) (2)
Conflict of interest: full disclosure is essential (2006) (2)
Brain cancer in interventional cardiologists and physicians – is occupational radiation exposure the cause? (2012) (2)
Women and heart disease: a British Heart Foundation initiative (2003) (2)
Stable and also unstable coronary disease – COURAGE and the importance of optimal medical therapy (2007) (2)
IMAGES IN CARDIOLOGY: LEFT VENTRICULAR FREE WALL RUPTURE (2001) (2)
Sexual dysfunction and the cardiac patient – no room for gender bias (1999) (2)
Vardenafil – PDE5 inhibitor number 3 (2004) (2)
Hypertension in women — not to be overlooked (1996) (2)
Viagra: a three‐year sexual revolution and the need to recognise its role within the NHS (2001) (2)
Lipids and cardiovascular risk reduction – new targets, new challenges (2005) (2)
Female sexual dysfunction: the BMJ fails to educate and fails to debate (2003) (2)
Believe‐it then PROVE‐IT (2004) (2)
Cardiology Current Perspectives (2007) (2)
Late onset hypogonadism in males – think of it – act on it (2012) (2)
Stable angina – medical therapy gives us time to optimise management (2004) (2)
Balloon pericardiotomy. (1994) (2)
Am I bothered? (2006) (2)
Obstructive sleep apnoea – a marker of increased cardiovascular risk (2012) (2)
Efficacy of aortic balloon valvoplasty: direct measurement of orificial area in a model with pulsatile flow. (1989) (1)
Statins in acute coronary syndromes: from bench to bedside (2001) (1)
Let’s talk about sex (2013) (1)
Abstract 2282: An Illness Perceptions Intervention to Address Cardiac Misconceptions and Increase Attendance at Cardiac Rehabilitation Post Myocardial Infarction: Results of a Pilot Randomised Controlled Trial (2006) (1)
Statins early in acute coronary syndromes (2000) (1)
ACE inhibitors after myocardial infarction (1995) (1)
Metabolic approach in heart failure (2005) (1)
Lipid‐lowering drugs: do the differences matter? (1999) (1)
Difficult concepts in cardiology (1994) (1)
Trimetazidine and the metabolic profile of ischemia (2006) (1)
Prevention of Cardiovascular Disease by Early Identification of ED (2007) (1)
Split screen analysis of stress echocardiography does not significantly improve sensitivity in detecting coronary artery disease (1996) (1)
Sodium cromoglycate for ACE inhibitor‐induced cough (1994) (1)
Earlyexercise testing andcoronaryangiography after uncomplicated myocardial infarction (1982) (1)
Postmenopausal hormone replacement therapy in hypertensive women: is it time for a change in attitude? (1998) (1)
Chest pain with normal coronary arteries (2008) (1)
‘CARDIAC CLAUDICATION’: ISCHAEMIC HEART DISEASE PRESENTING AS INTERMITTENT CLAUDICATION (1998) (1)
Beta‐blockers in heart failure (1995) (1)
Child abuse: a computerised register 40 years after it was proposed (2013) (1)
Trust me I'm a…Doctor? (2007) (1)
Hypertension: treating the patient as well as the blood pressure (2003) (1)
Erectile dysfunction – the right to be treated (1999) (1)
ENHANCE: food for the ostriches (2008) (1)
Complementary medicine and erectile dysfunction: will you accept the charges? (2011) (1)
Chronic stable angina – revised guidelines from the American College of Cardiology and American Heart Association (2008) (1)
HRT: Another piece of the coronary jigsaw (1995) (1)
Erectile dysfunction and coronary artery disease: the cardiac window opens (2009) (1)
Child abuse – a political, parental and religious syndrome (2000) (1)
The Polypill – multiple drug combinations are not the answer (2011) (1)
Talking about death –“I wish I could. . . .” (2004) (1)
Healthcare for the millennium: can we prevent a funding nightmare? (1996) (1)
Letter regarding article by Gazzaruso et al, "Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated, type 2 diabetic patients". (2005) (1)
Asymmetric septal hypertrophy and propranolol treatment in a case of Ullrich-Noonan syndrome. (1979) (1)
Seeds of doubt – ADVANTAGE no one (2008) (1)
Moderators 'i ntroduction (2002) (1)
Diabetes, statins and cardiovascular disease (2001) (1)
Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). (2006) (1)
Case reports (2005) (1)
Preventing coronary heart disease in women (2008) (1)
Sir Thomas Lewis: Pioneer Cardiologist and Clinical Scientist (1997) (1)
The politics of life, sex and the family – rediscovering priorities for 2007 (2007) (1)
Smoking cessation – medicine must triumph over politics (2008) (1)
Managing women with coronary artery disease (2002) (1)
Cardiac rehabilitation: an essential service (1992) (1)
Cardiac rehabilitation: exercising the heart (2000) (1)
Stable angina: two important trials – Rita‐2 and ACIP (1997) (1)
Hypertension: setting the treatment targets – a consensus emerges (1999) (1)
Acute coronary syndrome: are intervention and IIb/IIIa platelet inhibitors epiphenomena? (2001) (1)
Recognising and rewarding good performance: the importance of being valued (1999) (1)
The place of metabolic agents in the management of stable angina pectoris. (1999) (1)
Clinical benefits of a metabolic approach to the management of coronary patients (1999) (1)
Transition (2013) (1)
Epanolol. A new once-daily antianginal agent: dose finding and long term efficacy. (1989) (1)
Are you sure – the importance of “reasonable doubts” (2004) (1)
“Nuts, whole hazelnuts, Cadbury’s take ‘em and cover them with chocolate” (2010) (1)
The cardiac urologist (2007) (1)
Cardiovascular disease in the elderly. (1999) (1)
Cardiovascular risk and erectile dysfunction (2016) (1)
Vested interests — you and us (2000) (1)
Reducing cardiovascular risk (2012) (1)
Sexual activity and heart disease (1995) (1)
Sexual dysfunction and cardiovascular disease: a transatlantic consensus (2000) (1)
Smoking politics (2004) (1)
'No change for guidelines on GP prescribing of NHS impotence treatments' (No sex, please, we're New Labour) (2001) (1)
Erectile dysfunction increases cardiovascular risk: time to reduce it (2014) (1)
Difficult cardiology : practical management and decision-making (1990) (1)
Erectile dysfunction—a cardiovascular disease? (2003) (1)
Spending less – achieving more (2004) (1)
HRT and HERS: maintaining perspective (1998) (1)
Hyperventilation with coincidental cardiac arrhythmias: a diagnostic pitfall in patients with presyncope (1987) (0)
Orallabetalol inthe managementofstable angina pectoris innormotensive patients (1985) (0)
Communicating about death and dying (2011) (0)
Just Wars, People and Technology (1991) (0)
Transvenous cardioversion forthemanagement of recurrentventricular arrhythmias (2017) (0)
Effect of Partial Agonist Activity on the Side Effects of β-Blockade in Patients with Chronic Stable Angina (2012) (0)
Stable angina: clinical evaluation (2008) (0)
Lessons to be learned – the blame culture (2001) (0)
Underfunding : the reality exposed (1991) (0)
Checklists will help us stay SHARP (1996) (0)
infarction: correlation with findings on exercise electrocardiography and coronary angiography (1985) (0)
Erectile dysfunction as a diagnostic indicator (2009) (0)
Angina, myocardial hibernation and trimetazidine (1997) (0)
Making money out of babies: rights without responsibility (1996) (0)
PROVE IT-TIMI 22 arly and Late Benefits of High-Dose Atorvastatin n Patients With Acute Coronary Syndromes esults From the PROVE IT-TIMI 22 Trial (2016) (0)
Blood pressure guidelines – unlocking the evidence remains challenging (2009) (0)
Stable angina: treatment selection (2010) (0)
Female sexual dysfunction is being medicalized by the pharmaceutical industry: Con (2004) (0)
Cardiovascular aspects of erectile dysfunction (2004) (0)
And so this is Christmas – (2012) (0)
Specific cardiac conditions and sex (2004) (0)
Shine a little light – a concert for peace (2007) (0)
Statins and strokes – reducing the risk (1999) (0)
Going up in smoke (1993) (0)
Angina in the elderly: the need for a balanced approach (2001) (0)
Hormones and the heart (2015) (0)
A Difficult Case: How should a patient presenting with unstable angina and a recent stroke be managed?: Patient needs carotid artery surgery (1995) (0)
The importance of a metabolic approach to anti-ischemic (2007) (0)
Prejudice and perspective (2003) (0)
Sex and cardiac risk (2004) (0)
Primary angioplasty in acute myocardial infarction – the preferred option, but time is of the essence (2006) (0)
Where would you choose to have a coronary angiogram? (1996) (0)
Sexual health: the 4th Congress of the ESSIR, 2001 (2001) (0)
Beta‐blockers for uncomplicated hypertension – mugged by armchair scientists? (2005) (0)
HRT and SERMS – increasing benefit, reducing risk? (1998) (0)
A two‐tier NHS in a two‐tier world — time for change (2003) (0)
Case 4. Coronary Heart Disease In A Premenopausal Woman (2006) (0)
Increased diastolic blood pressure response to exercise testing when coronary artery disease is suspected Patients and methods STUDY POPULATION (0)
IJCP moves online for submission and peer review (2005) (0)
Case Reports (2002) (0)
Cigarette deaths, cigarette advertisements, cigarette recruits, cigarette money (1996) (0)
Medicine and the media — education, not exploitation (1996) (0)
‘THEM AND US’ PHILOSOPHY IN THE TREATMENT OF AIDS (1991) (0)
Suicide: using a tragedy to prevent tragedy (2003) (0)
The metabolic syndrome conundrum (2008) (0)
Pathological specimen examinations (2001) (0)
INTRACORONARY NITRATES MAY AVOID UNNECESSARY ANGIOPLASTY (1997) (0)
Early exercise testing andelective coronaryartery bypass surgeryafter uncomplicated myocardial (1984) (0)
Evaluating the athlete’s heart – now and in the future (2012) (0)
Doppler echocardiographic appearance of cusp tears in tissue valve prosthesis. (1987) (0)
Chronic aspirin therapy inhibits activation of nitric oxide synthase by beta-adrenergic agonists in platelets (2001) (0)
The cardiovascular potential of PDE5 inhibitors (2004) (0)
Textbook of Interventional Cardiology, 2nd ednEric JTopol (and 110 other contributors). London: WB Saunders, 1993, 1520 pp (in 2 vols), £138 (1995) (0)
Testosterone replacement therapy : cardiovascular benefits and possible risks . (2015) (0)
The management of stable angina. (1993) (0)
Comprar Angina, Fourth Edition | Graham Jackson | 9781841846699 | Informa Healthcare (2008) (0)
Evil: origins and potential solutions (2002) (0)
The Hemodynamics of Phosphodiesterase-PDE5 Inhibitors (2004) (0)
beta-adrenoceptor activation of platelet nitric oxide synthase is impaired in patients with coronary atherosclerosis (2000) (0)
Men's health: Is your willy working? (2013) (0)
Drug Therapy in Cardiology : Current Perspectives (2001) (0)
Men’s health in Europe – no room for complacency (2012) (0)
Coronary artery disease in women: Awareness and fairness (1994) (0)
Clinical Hypertension, 6th ednNorman MKaplan. Williams & Wilkins, 1994, 482 pp, £65 (1995) (0)
Diagnosis ofcoronaryartery disease byestimation ofcoronarysinus lactate (1978) (0)
ABC of Atrial Fibrillation Edited by GregoryYH LipLondon: BMJ Publishing Group, 1996, 36pp; •10.95 (1997) (0)
Sexual medicine is preventative medicine (2012) (0)
Sexual advice: careful driving is needed along a road well travelled (2009) (0)
Sildenafil and cardiovascular events — drug interactions (2004) (0)
Divergent effects of short- and long-term exposure to aspirin on basal and beta-adrenoceptor stimulated nitric oxide synthase activity in platelets (2002) (0)
Free at the point of entry? (1993) (0)
Angina, Fourth Edition (2008) (0)
Stable angina pectoris (recognition and management) (2005) (0)
Anticoagulant therapy and direct current cardioversion of patients with atrial fibrillation or atrial flutter (1992) (0)
Would sir like to see the wine list? (2010) (0)
Blood pressure and cardiovascular risk reduction – new targets, new challenges (2005) (0)
Supraventricular Arrhythmias — Digoxin and Quinidine Revisited (1985) (0)
An indication of severity (0)
Berlin, cardiology, and visions of the inferno (1994) (0)
Risk factor management: the cardiologist's perspective. (1994) (0)
ASTEROID – when spinning a star leads to a collision with reality (2006) (0)
Prevention of disease – education makes a difference in the community (2005) (0)
A Women's Heart Disease Clinic - Audit of the First Year (2001) (0)
Angiographic benefits from lipid‐lowering in the clinical context (1997) (0)
Looking for the ‘way forward‘ (1993) (0)
The twists of fate ‐ the role of chance ‐ the joy of life (2002) (0)
Counselling and education of patients (2000) (0)
Health care and the ‘blinkers syndrome‘ (1991) (0)
Patient needs carotid artery surgery (1995) (0)
Controversies in cardiology. (1998) (0)
Listen: testosterone is no longer a secret (2010) (0)
Coronary heart disease in a premenopausal woman (2006) (0)
Pressure of work and overtime shortens life (2011) (0)
Acute systemic aspirin administration increases basal but suppresses beta(2)-adrenoceptor-stimulated forearm blood flow (2006) (0)
Tobacco regulation — does tax income come before health? (1996) (0)
MIST – patching up the differences and the need for an independent overview (2009) (0)
Introduction (2005) (0)
Diagnosis of chest pain (2008) (0)
Treating erectile dysfunction in cardiac patients (2004) (0)
A prank too far (2013) (0)
Some thoughts on chronic heart failure (1993) (0)
Coronary disease in the elderly (2008) (0)
Comparison ofatenolol with propranolol inthe treatment ofangina pectoris withspecial reference tooncedaily administration ofatenolol (1978) (0)
Heart failure — losing friends (1994) (0)
Left Ventricular Hypertrophy (and its regression)JMCruikshank, FHMesserli, eds. Science Press, 1992, 107 pp (1994) (0)
Current approaches to stable angina. (1996) (0)
'Is there a doctor on board?' The need for airlines and doctors to share a collective responsibility for medical safety. (1998) (0)
THE MENAGEMENT OF STABLE ANGINA (1993) (0)
Cardiology update. Balloon pericardiotomy. (1994) (0)
A-06Mental Health and Demographic Characteristics, But Not Parental History, Influence Subjective Ratings of Cognitive Functioning (2017) (0)
METEOR: aiming at the stars for asymptomatic carotid artery atherosclerosis? (2007) (0)
Losing good friends and good people (2012) (0)
Standard operative procedures in sexual medicine: a cardiological vacuum (2013) (0)
Female sexual dysfunction (2004) (0)
Erectile Dysfunction as an ‘Early Diagnostic Window’ for Asymptomatic Coronary Artery Disease (2015) (0)
A Difficult Case: Patient needs carotid artery surgery (1995) (0)
Sex and the heart – the physiological response (2004) (0)
The importance of inhibiting free fatty acid metabolism in heart failure treatment (2007) (0)
Editorial comment on: Amino-terminal pro-C-type natriuretic peptide is associated with the presence, severity, and duration of vasculogenic erectile dysfunction. (2009) (0)
Colour flowDoppler mappingintheassessmentof prosthetic valve regurgitation (1989) (0)
AQ 3 Breathlessness and damaging lifestyle in a patient with prediabetes : will trimetazidine help ? (2007) (0)
Phosphodiesterase inhibition: erectile dysfunction is only part of the story (2002) (0)
Touching a chord – on being a doctor (2002) (0)
Caution: critical illness policies (2011) (0)
Echocardiography. (1988) (0)
Generic prescribing – the chaos continues (2005) (0)
The Management of Angina (1987) (0)
Hormone Replacement Therapy and Cardiovascular Disease: Are the Cardiovascular Benefits Established? (2002) (0)
Viagra and male erectile dysfunction: prescribing restrictions should be abolished (2000) (0)
The long and the short of it all (1992) (0)
Risk factor management: the cardiologist's perspective. (1996) (0)
The challenge of unstable angina. (1996) (0)
Erectile dysfunction: the problem (2004) (0)
Equality of care for the elderly (2011) (0)
The continuity equation tested in a bileaflet tilting disc aortic prosthesis (1991) (0)
Coronary disease in women (2006) (0)
Tirofiban – spinning the data from fact to hype (1997) (0)
A case of percutaneous balloon mitral valvuloplasty for severe symptomatic mitral stenosis in an octogenarian. (2001) (0)
She should have been at home having tea and cakes (2002) (0)
Secondary prevention of stroke: PROGRESS and the evidence for blood pressure reduction. (2001) (0)
We-P11:268 Cardiovascular risk factors determine erectile and arterial response to sildenafil (2006) (0)
Reflections (2005) (0)
Conflicts and Finance: Disclosure still incomplete (2008) (0)
Increased diastolic blood pressureresponsetoexercise testing whencoronaryarterydisease issuspected Anindication ofseverity (1985) (0)
Early Exercise Testing and Coronary Bypass Surgery Post-infarction (1984) (0)
administration of atenolol . reference to once daily angina pectoris with special propranolol in the treatment of Comparison of atenolol with (0)
Systolic heart failure: no room for complacency (2000) (0)
‘Hate is a crime of the spirit that leads to crimes of the flesh’ (2001) (0)
The heart of an athlete (2012) (0)
Cardiovascular Issues in the Treatment of Erectile Dysfunction (2011) (0)
Painful reflections (2007) (0)
Cardiac sexology: can we save a patient's life and his love life? (2008) (0)
Cardiovascular effects of testosterone (2008) (0)
Case reports (2005) (0)
Trimetazidine and left ventricular dysfunction : patients must play their part also (2007) (0)
Efficacy of nifedipine and isosorbide mononitrate in combination with atenolo in stable angina. Commentary (1992) (0)
Difficult cardiology III (1997) (0)

This paper list is powered by the following services:

Graham Frcp Jackson's Academic­Influence.com Rankings

Graham Frcp Jackson's Degrees

Why Is Graham Frcp Jackson Influential?

Graham Frcp Jackson's Published Works

Published Works

Graham Frcp Jackson's AcademicInfluence.com Rankings